• Guideline Summary
  • NGC:010373
  • 2013 Sep

Optimal use of taxanes in metastatic breast cancer (MBC).

  • Guideline Summary
  • NGC:010054
  • 2007 Jan 1 (revised 2013 Nov 1)

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  • Guideline Summary
  • NGC:009352
  • 2004 May (revised 2012 Oct)

Cancer screening.

  • Guideline Summary
  • NGC:010699
  • 2014 Sep 29

Locoregional therapy of locally advanced breast cancer (LABC).

  • Guideline Summary
  • NGC:010904
  • 2016 Feb 16

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:010705
  • 2014

WHO position paper on mammography screening.

  • Guideline Summary
  • NGC:010174
  • 1996 (revised 2013)

ACR Appropriateness Criteria® local-regional recurrence (LRR) and salvage surgery—breast cancer.

  • Guideline Summary
  • NGC:009677
  • 1996 (revised 2012)

ACR Appropriateness Criteria® spinal bone metastases.

  • Guideline Summary
  • NGC:009657
  • 1996 (revised 2012)

ACR Appropriateness Criteria® nonpalpable mammographic findings (excluding calcifications).

  • Guideline Summary
  • NGC:009311
  • 2012 Aug

Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

  • Guideline Summary
  • NGC:010672
  • 1996 (revised 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

  • Guideline Summary
  • NGC:009736
  • 2007 Jun (revised 2013 Apr)

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

  • Guideline Summary
  • NGC:010011
  • 2013 Aug

Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy.

  • Guideline Summary
  • NGC:010022
  • 1998 Oct (revised 2013 Sep)

Treatment of primary breast cancer. A national clinical guideline.